Haian Fu

23.0k citations

221 papers · 17.4k indexed · 3 hit papers · h-index 59

Impact in

Molecular Biology top 0.2%
- 14-3-3 protein interactions
- Ubiquitin and proteasome pathways
- PI3K/AKT/mTOR signaling in cancer
- Cell death mechanisms and regulation
- Protein Kinase Regulation and GTPase Signaling
Cell Biology top 0.5%

Papers in

Molecular Biology 189
- 14-3-3 protein interactions 65
- Ubiquitin and proteasome pathways 53
- PI3K/AKT/mTOR signaling in cancer 17
- Protein Kinase Regulation and GTPase Signaling 14
- Heat shock proteins research 13
Cell Biology 28

Co-authors: Shane C. Masters Sandeep Robert Datta Yukiko Gotoh Xu Tao Michael E. Greenberg Henryk Dudek Romesh R. Subramanian Fadlo R. Khuri
Journals: Journal of Biological Chemistry (19 papers)Proceedings of the National Academy of Sciences (8 papers)Nature Communications (6 papers)Journal of Molecular Cell Biology (6 papers)Cancer Research (5 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Haian Fu

212 papers receiving 17.1k citations

Hit Papers

align trajectories log scale

Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition 2005 · 682 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 Cancer Research
2000 The Annual Review of Pharmacology and Toxicology
1997 Cell

Peers

Countries citing papers authored by Haian Fu

Since Specialization

Citations

This map shows the geographic impact of Haian Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haian Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haian Fu more than expected).

Fields of papers citing papers by Haian Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haian Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haian Fu. The network helps show where Haian Fu may publish in the future.

Co-authors

The 25 scholars most cited alongside Haian Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haian Fu Line = papers co-authored together Haian Fu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exosomes derived from ADSC suppress endothelial cells ferroptosis and alleviate sepsis acute liver injury via regulation of Keap1/Nrf2/GPX4 axis Stem Cells ·Xianqi Wang, Dan Wu, Xiaoyang Liu, Yanan Xu, Peiwen Wang, Haian Fu, 小出水規行, علا مكطوف شنيور, Qianmei Wang, William Burnidge, Zheng Dai, Qi Zhang, L. L. Emanuel, Kuo Shen, Junjie Li	2025	0
2	Vanadium modulated Ni-MoSe2 as highly efficient electrocatalyst for alkaline hydrogen evolution Journal of Molecular Structure ·Hongyan Zhang, Lin-lin Guo, Hua Wang, Yikai Wang, Ranran Li, Haian Fu, Hao Zhou, Dan Wu, ValérieVergeur, Maoshuai He, Wenxian Wei, Tao Yang	2024	3
3	Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction SLAS DISCOVERY ·理宇都宮, Dongxue Wang, V.L. Katis, Ana Carolina Lourenço de Barros, Min Qui, Allan I. Levey, O. Gileadi, Haian Fu	2024	2
4	Discovery of FERM domain protein–protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer’s disease Journal of Biological Chemistry ·Yuhong Du, W.J. Bradshaw, Meneses Fernando, A. J. McNairn, Kun Qian, Myriam Abouzaïd, J. D. Dorman, R. Reichelt, Andrei A. Ivanov, Stephen V. Frye, O. Gileadi, Paul E. Brennan, Allan I. Levey, Alison D. Axtman, Kenneth H. Pearce, Haian Fu, V.L. Katis	2023	8
5	Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion Nature Communications ·Belle Payton, Changyong Wei, Aditi Sharma, Janna K. Mouw, Liza J. Burton, 斉藤孝夫, Eva Šuránková, CHRISTOPHER MONZ, Jessica Konen, Wei Zhou, Wetshodima Yole Yalonga, Haian Fu, Mala Shanmugam, Adam I. Marcus	2020	82
6	Expression and purification of active human kinases using Pichia pastoris as a general-purpose host Protein Expression and Purification ·May H. Abdel Aziz, Mainuddin AKM, Lijun Liu, Mark M. Moasser, Haian Fu, Natalia Jura, Michelle R. Arkin	2020	1
7	Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer Molecular Cancer Therapeutics ·Yang Yang, Abubakr Mohammadian, Xin Li, Yanhua Chen, Nicolas Dowdy, Yuhong Du, Haian Fu, Ömer Küçük, Daqing Wu	2018	20
8	Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction Assay and Drug Development Technologies ·NingYang Xu, Valentina González-Pecchi, Min Qui, Andrei A. Ivanov, Xiulei Mo, Qiankun Niu, Xiang Chen, Haian Fu, Yuhong Du	2018	15
9	Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors Assay and Drug Development Technologies ·Charline Giroud, Yuhong Du, Mariana Marin, Yan Yunzhi, Nathan T. Jui, Haian Fu, Gregory B. Melikyan	2017	5
10	High-Throughput HIV–Cell Fusion Assay for Discovery of Virus Entry Inhibitors Assay and Drug Development Technologies ·Mariana Marin, Yuhong Du, Charline Giroud, Jeong Hwa Kim, Min Qui, Haian Fu, Gregory B. Melikyan	2015	27
11	Cables1 Complex Couples Survival Signaling to the Cell Death Machinery Cancer Research ·Zhi Shi, Hae Ryoun Park, Yuhong Du, Zijian Li, Kejun Cheng, Shi‐Yong Sun, Zenggang Li, Haian Fu, Fadlo R. Khuri	2014	33
12	A Time-Resolved Fluorescence Resonance Energy Transfer Assay for High-Throughput Screening of 14-3-3 Protein–Protein Interaction Inhibitors Assay and Drug Development Technologies ·Yuhong Du, Spencer S. Liem, Bin Lou, Jing Zhao, Min Qui, Fadlo R. Khuri, Haian Fu	2013	22
13	Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway Oncology Reports ·Meijuan Chen, Yuhong Du, Min Qui, Mingyan Wang, Kejun Chen, Guohui Nan, Miao Jiang, Fei Xiong, Jianping Chen, Jing Zhou, Jiang Fengrong, Lian Yin, Yuridia Herrera, Lihong Ye, Zhen Zhan, Jin‐Ao Duan, Haian Fu, Xu Zhang	2012	70
14	14-3-3η Amplifies Androgen Receptor Actions in Prostate Cancer Clinical Cancer Research ·Mark Titus, Jiann-an Tan, Christopher W. Gregory, O. Harris Ford, Romesh R. Subramanian, Haian Fu, Elizabeth M. Wilson, James L. Mohler, Frank S. French	2009	13
15	Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening Molecular Cancer Therapeutics ·Agnieszka B. Bialkowska, Yuhong Du, Haian Fu, Vincent W. Yang	2009	31
16	Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation Cancer Research ·Xuerong Wang, Ping Yue, Young Ae Kim, Haian Fu, Fadlo R. Khuri, Shi‐Yong Sun	2008	135
17	A Homogenous Luminescent Proximity Assay for 14-3-3 Interactions with Both Phosphorylated and Nonphosphorylated Client Peptides PubMed ·Yuhong Du, Fadlo R. Khuri, Haian Fu	2008	16
18	Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation Proceedings of the National Academy of Sciences ·Zenggang Li, Jing Zhao, Yuhong Du, Hae Ryoun Park, Shi‐Yong Sun, Leon Bernal‐Mizrachi, Alastair Aitken, Fadlo R. Khuri, Haian Fu	2007	128
19	Photic regulation of arylalkylamine N-acetyltransferase binding to 14-3-3 proteins in retinal photoreceptor cells Journal of Neuroscience Nursing ·Nikita Pozdeyev, Carla G. Taylor, Rashidul Haque, Shyam S. Chaurasia, Amy Visser, R. Ahanessians, Yuhong Du, Haian Fu, Joan L. Weller, David C. Klein, P. Michael Iuvone	2006	2
20	Protein-protein interactions : methods and applications Humana Press eBooks ·Haian Fu	2004	58

About Haian Fu

Haian Fu is a scholar working on Molecular Biology, Cell Biology, Molecular Medicine, Cancer Research and Pharmacology, having authored 221 papers that have together received 17.4k indexed citations. Recurring topics across this work include 14-3-3 protein interactions (65 papers), Ubiquitin and proteasome pathways (53 papers), Microbial Natural Products and Biosynthesis (18 papers), PI3K/AKT/mTOR signaling in cancer (17 papers), Computational Drug Discovery Methods (17 papers), Protein Kinase Regulation and GTPase Signaling (14 papers), Cancer-related Molecular Pathways (13 papers) and Heat shock proteins research (13 papers). The work is most often cited by research in Molecular Biology (13.5k citations), Cell Biology (1.7k citations), Cancer Research (1.5k citations), Oncology (2.6k citations) and Immunology (1.7k citations). Haian Fu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Shane C. Masters, Sandeep Robert Datta, Yukiko Gotoh, Xu Tao, Michael E. Greenberg, Henryk Dudek, Romesh R. Subramanian, Fadlo R. Khuri, Lixin Zhang and Yuhong Du. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Nature Communications, Journal of Molecular Cell Biology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact